Scientists have discovered that licorice extract, a common traditional herb, offers powerful protection against Paraclostridium bifermentans spores—a heat-resistant microbe that threatens the safety and shelf life of ready-to-eat (RTE) chicken breast. In laboratory tests, licorice extract concentrations above 12.5 mg/mL significantly suppressed spore growth, while a 50 mg/mL dose nearly doubled product shelf life at 15 and 20 °C. Predictive modeling confirmed the extract’s impact on microbial growth rates and lag phases. Moreover, treated chicken samples showed slower spoilage, with lower acidity and chemical breakdown. The findings open up new possibilities for natural, plant-based preservation strategies in the meat industry.

Targeted drug delivery to tumors is crucial for effective and safe treatment of cancer. In a recent breakthrough, researchers from Okayama University have developed a pH-responsive nanomaterial using graphene oxide and polyglycerol for cancer drug delivery. The surface of the developed nanomaterial changes its charge in an acidic tumor environment and enables uptake of drugs by cancer cells while avoiding immune clearance. This innovative approach opens doors to precision-driven and more efficient cancer therapies.

Autophagy is a process in which worn out, toxic or degraded cellular components are swept up and recycled to maintain a healthy living cell. When this process is disrupted or disfunctions, it can lead to diseases such as cancer, neurodegeneration, and heart disease.

All our cells have a self-cleaning system known as autophagy, which degrade unwanted materials. And now researchers from Aarhus University have found an important “switch” regulating this key process. A find that could lead to ways to prevent and eventually treat illnesses such as dementia, ALS and cancer.

A study led by researchers from the University of Michigan showed that targeting CDK12 and a related gene, CDK13, strongly activates the stimulator of interferon genes, or STING, signaling pathway, enhancing the effectiveness of immunotherapies.

Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called "O2E" that allows clinics to detect cancerous lesions in the esophagus with unprecedented precision. Published in Nature Biomedical Engineering, the study demonstrates that this innovative endoscopy technology reveals even the smallest pathological tissue changes, significantly improving early detection and diagnosis.